Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge

BACKGROUND: Ebola virus (EBOV), variant Makona, was the causative agent of the 2013–2016 West African epidemic responsible for almost 30,000 human infections and over 11,000 fatalities. During the epidemic, the development of several experimental vaccines was accelerated through human clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzi, Andrea, Reynolds, Pierce, Mercado-Hernandez, Reinaldo, Callison, Julie, Feldmann, Friederike, Rosenke, Rebecca, Thomas, Tina, Scott, Dana P., Hanley, Patrick W., Haddock, Elaine, Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945200/
https://www.ncbi.nlm.nih.gov/pubmed/31631035
http://dx.doi.org/10.1016/j.ebiom.2019.09.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945200/
https://www.ncbi.nlm.nih.gov/pubmed/31631035
http://dx.doi.org/10.1016/j.ebiom.2019.09.055

Ejemplares similares